BOC Report and accounts 2005 - Alle jaarverslagen

94 The BOC Group plc Annual report and accounts 2005 Notes to the financial statements
1. Segmental information continued
c) Regional analysis
Total
Europe Americas Africa Asia/Pacific Group
£ million £ million £ million £ million £ million
2005
Total operating profit before exceptional items 1 143.7 100.0 91.3 229.2 564.2
Operating exceptional items 1 (5.1) (15.6) – – (20.7)
Operating profit 138.6 84.4 91.3 229.2 543.5
Profit on disposal of businesses – 13.2 84.9 – 98.1
Profit on disposal of fixed assets – 10.5 – – 10.5
Capital employed 2 774.2 1,143.2 203.4 1,163.6 3,284.4
Capital expenditure 3 105.1 133.0 45.8 113.4 397.3
2004
Total operating profit before exceptional items 1 155.4 77.4 108.9 235.2 576.9
Operating exceptional items 1 – (14.8) – (2.6) (17.4)
Operating profit 155.4 62.6 108.9 232.6 559.5
Loss on disposal of business – (79.5) – – (79.5)
Profit on disposal of fixed assets 4.9 – – – 4.9
Capital employed 2 796.6 992.9 335.4 1,095.5 3,220.4
Capital expenditure 3 72.3 71.8 44.2 67.8 256.1
2003
Total operating profit before exceptional items 1 144.3 91.8 85.0 184.5 505.6
Operating exceptional items 1 (7.3) (49.1) – (10.6) (67.0)
Operating profit 137.0 42.7 85.0 173.9 438.6
Capital employed 2 866.2 1,225.0 321.5 1,244.4 3,657.1
Capital expenditure 3 102.7 79.1 36.7 62.7 281.2
1. Including share of joint ventures and associates.
2. Capital employed comprises the capital and reserves of the Group, its long-term liabilities and all current borrowings net of cash and deposits.
3. Subsidiary undertakings only.
4. Net interest and net borrowings are managed centrally and are not directly attributable to individual business segments or regions.
5. The Afrox hospitals business was accounted for as a subsidiary company until March 2005 and thereafter as an associated company, following the disposal of BOC’s controlling interest.
d) Joint ventures and associates – business analysis
Joint ventures
Associates
Industrial
Industrial
Process Gas and Special BOC Process Gas and Special BOC Afrox
Solutions Products Edwards Solutions Products Edwards hospitals
£ million £ million £ million £ million £ million £ million £ million
2005
Turnover 1 287.9 244.9 195.0 51.7 7.6 5.5 57.7
Operating profit before exceptional items 1 44.6 31.6 30.9 8.9 0.5 1.2 9.9
Operating exceptional items 1 – – – – – – –
Operating profit 44.6 31.6 30.9 8.9 0.5 1.2 9.9
Capital employed 2 116.7 67.0 107.8 42.7 5.0 2.2 30.8
Capital expenditure 192.2 17.8 54.3 2.2 1.6 – 17.8
Group share 106.3 8.2 26.4 0.6 0.5 – 2.0
Other partners 85.9 9.6 27.9 1.6 1.1 – 15.8
Depreciation and amortisation 1 32.7 10.3 11.2 2.8 0.6 0.1 0.8
2004
Turnover 1 230.0 238.9 178.1 36.3 7.7 5.5 17.4
Operating profit before exceptional items 1 40.8 30.4 28.2 6.3 0.7 1.4 4.7
Operating exceptional items 1 (0.8) (0.8) (1.0) – – – –
Operating profit 40.0 29.6 27.2 6.3 0.7 1.4 4.7
Capital employed 2 89.5 69.3 99.9 35.3 4.9 2.5 9.7
Capital expenditure 58.5 15.5 30.1 2.1 2.7 0.1 –
Group share 25.7 7.4 14.8 0.6 0.7 – –
Other partners 32.8 8.1 15.3 1.5 2.0 0.1 –
Depreciation and amortisation 1 27.0 10.2 10.1 2.7 0.5 0.1 1.0
1. Group share.
2. Capital employed comprises the Group’s share of the net assets of joint ventures or associates.
3. The decrease in capital employed of joint ventures in 2004 is principally due to the acquisition of an additional 30 per cent ownership interest in the Cantarell joint venture (see note 28a)).
4. The Afrox hospitals business was accounted for as a subsidiary company until March 2005 and thereafter as an associated company, following the disposal of BOC’s controlling interest.